It's non-hormonal, requires no PCT, stacks cleanly with anything, and uniquely among peptides actually works topically because the molecule is small enough to penetrate the stratum corneum
When Cigna covers Wegovy, typical PA requirements include: BMI 30 or 27 with a comorbidity (hypertension, type 2 diabetes, OSA, or cardiovascular disease), 3 months of documented lifestyle modification (diet and exercise program), and you cannot be taking another GLP-1 medication simultaneously
Any product claiming FDA approval for a compounded sermorelin formulation is making a factually incorrect claim
TABLE 5 Results of inBio discover annotation analysis with the top 10 and custom-made DOID annotations associated with chronic fatigue spectrum disorders
Beyond product quality, self-administering without a health screening means youre skipping the step where someone checks whether BPC-157 is appropriate for your specific situation
This small size enables efficient penetration of biological barriers, including the skin